david howse

@indy5001 @vaderviz @imyycooper Remember the elbow Wemby hit Naz Reid with? Check out what Malone did to David Robinson.

@vaderviz @imyycooper Read my post, run circles around them...or if he's bored bench press them.

First 3 minutes of the 1998 Game 6 NBA Finals Basketball used to be so pure 🔥

@bradloncar (1) why was the Vela-teen trial completion date extended from March 31 to some time in August? (2) have enough people completed 52 weeks in the vella 1 and 2 trials - how many are at week 52, how many more needed?

Tomorrow I’m doing BiotechTV from the RBC Conference in New York. One of the first company interviews in the morning will be $MLTX. What questions do we have about that one?

@uscfan981 Mostly, but I consider Wilt a 76er

Is this accurate?

@CodyMitchell73 These are all the same person trying to get you to send a WhatsApp 🤣

$MLTX: MoonLake presents Week 40 Phase 3 data for sonelokimab in HS at AAD 2026. Key level to watch is the stock's reaction to long-term efficacy and safety results. Volatility expected. Risk management is key here.

@cameron_do_90 These are all the same person trying to get you to send a WhatsApp 🤣

Just in: $MLTX announces Week 40 data for its Phase 3 HS trial. Long-term results for sonelokimab presented at AAD. Monitor for sector rotation and trading volume.

@dylan_hart38 These are all the same person trying to get you to send a WhatsApp 🤣

🚨 $MLTX: MoonLake Unveils Week 40 Phase 3 Data for Sonelokimab in HS at AAD 2026. 1. Long-term results from VELA-1 & VELA-2 trials demonstrate sustained efficacy. 2. Signals potential for a best-in-class inflammatory disease therapy.

@gregory_wafeed These are all the same person trying to get you to send a WhatsApp 🤣

@james_wilsfeel These are all the same person trying to get you to send a WhatsApp 🤣

Is $MLTX ready for a breakout? MoonLake reports strong Week 40 Phase 3 data for sonelokimab in HS. Watch key support levels as volume spikes.

@benjamin_h06 These are all the same person trying to get you to send a WhatsApp 🤣

@zachary_be_post What do you mean, "holding key support"? The presentation was today - Saturday.

BREAKING: $MLTX announces strong Week 40 Phase 3 data for sonelokimab in HS. The stock is holding key support after the AAD presentation. Sector rotation likely—consider options for positioning on this clinical catalyst. 📢

@LifetimeIP @oldskoolbballx In an interview many years ago, Parish said Bill was lucky because Parish's arthritis in his hands was acting up and he couldn't make a proper fist.

@oldskoolbballx Did you notice nobody came after Parish? There are 2 reasons. First, everyone hated Laimbeer, not just the Celtics. Second, Parish was a bad ass and would have destroyed them. Mostly the first reason though.

Robert Parish ruthlessly KOs Bill Laimbeer, and he doesn’t even get ejected by the refs

@Salyma0 @asaadhanna You are aware that his father also had blood on his hands? Why was the revolution so quick in the 70s? Flipping back and forth between extremes is not what Iran needs.

@asaadhanna We love Rubio and all these memes about him. But, seriously, not this one! We have our own Shah that we love so much 💚🤍❤️

Rubio finding out he needs to be the Shah of Iran in 72 hours.

Could you imagine paying for this advice? Twitter is full of morons who make 1000s of claims and bs analysis, hoping you find the self confirming bias you were looking for.

@Riahlicious_xx @xpjw8gydbp Why no mention of the FDA Type B meeting 30 day expiry approaching and the JP Morgan conference just before the mentioned expiry? You skipped the 2 biggest details.

@xpjw8gydbp Detailed trading strategies are available in the group chat.

$MLTX: The "Fallen Angel" Trade. Dead Cat Bounce or Real Reversal? 🐈⬛📉 Body:Let’s talk about the elephant in the room: $MLTX. Since the 90% haircut on the VELA trial data in Sept, this ticker has been a battleground. We saw it flush to ~$6 and now it's fighting to hold the $11-$13 range. The volatility we are seeing right now is textbook "capitulation vs. accumulation." Why is it moving wildly? Insider Selling Fear: The CSO just unloaded ~$3M in stock. The market hates seeing insiders sell into weakness, triggering panic dumps. The Buyout Thesis: Remember the rumors of Merck ($MRK) eyeing them for $3B+ last year? Now that $MLTX is trading under $1B market cap, the "vultures" are circling. Big Pharma loves buying distressed assets with good IP (Nanobodies). 🦅 Short Covering: With short interest sky-high after the crash, any small bounce triggers a squeeze as bears lock in profits. My Setup:I’m watching the $10.50 level like a hawk. If we hold this support, the "Gap Fill" trade back to $18 is on the table. If it breaks, we retest the lows. Risk/Reward is insane here. 📉 Don't catch a falling knife without a plan. I have a specific entry zone and stop-loss plan for this high-risk play.👇 Add me on WhatsApp to get my trade plan:wa.me/17328693283 #MLTX #Biotech #StockMarket #ContrarianTrading #ShortSqueeze #DayTrading #PennyStocks #WallStreet #RiskManagement

@dy_gbl The same morons complaining that low gas prices are a sign of a weak economy are the same ones complaining when we were $1.60 🤡🤡🤡

Sorry guys, I'm now Mark Carney's strongest soldier

@RBC I just want to confirm the idea you just gave me on how to start a fradulent business: sell legitimate products at a discount, add overnight delivery fee, only pay for regular delivery, keep the difference. Visa dispute said I have a weak case for refund. true?

@TheAdwenKese3 @Wisdom_HQ @grok 21

@Wisdom_HQ @grok what’s the answer

@Wisdom_HQ 21. 7 men and each is married to one woman, totalling 7 wives. Each couple has 1 child, totalling 7 children. It never said they have 7 children each, just 7 children.

@theamelia__ Read this letter

@Robbinsllp Lol. I wish there was somewhere we could bet against this action going nowhere.

Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics $MLTX Mislead Investors Regarding the Efficacy of its Drug Candidate. #MLTX #StockWatch robbinsllp.com/moonlake-immun…